title: The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders.
abstract: Chronic microglial activation is an important component of many neurological disorders, and imaging activated microglia in vivo will enable the detection and improved treatment of neuroinflammation. 1-(2-chlorphenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline-carbox-amide (PK11195), a peripheral benzodiazepine receptor ligand, has been used to image neuroinflammation, but the extent to which PK11195 binding distinguishes activated microglia and reactive astrocytes is unclear. Moreover, PK11195 may lack sufficient sensitivity for detecting mild neuroinflammation. We hypothesized that N-(2,5-dimethoxybenzyl)-N-(4-fluoro-2-phenoxyphenyl) acetamide (DAA1106), a new ligand that binds specifically to peripheral benzodiazepine receptor, binds to activated microglia in human neurological diseases with higher affinity than does PK11195. We therefore compared the pharmacological binding properties of [3H](R)-PK11195 and [3H]DAA1106 in postmortem tissues from patients with cerebral infarcts, amyotrophic lateral sclerosis, Alzheimer disease, frontotemporal dementia, and multiple sclerosis (n=10 each). In all diseases, [3H]DAA1106 showed a higher binding affinity as reflected by lower dissociation constant (KD) values than that of [3H](R)-PK11195. Moreover, specific binding of both ligands correlated with the presence of activated microglia identified by immunohistochemistry in situ. We conclude that 1) ligands that bind peripheral benzodiazepine receptor mainly label activated microglia in human neurological disorders and that 2) DAA1106 may possess binding characteristics superior to those of PK11195, which may be beneficial for in vivo positron emission tomography imaging.
authors.affiliation: Department of Pathology, University of Pittsburgh School of Medicine, and Presbyterian University Hospital, Neuropathology Division, Pittsburgh, Pennsylvania 15213, USA.
authors.forename: Sriram
authors.initials: S
authors.lastname: Venneti
authors.forename: Guoji
authors.initials: G
authors.lastname: Wang
authors.forename: Jason
authors.initials: J
authors.lastname: Nguyen
authors.forename: Clayton A
authors.initials: CA
authors.lastname: Wiley
mesh_terms: D000081:Acetamides / Q000493:pharmacokinetics*; D000368:Aged; D000369:Aged, 80 and over; D001345:Autoradiography; D001921:Brain / Q000473:pathology; D005260:Female; D006801:Humans; D007249:Inflammation / Q000000981:diagnostic imaging / Q000473:pathology; D007546:Isoquinolines / Q000493:pharmacokinetics; D008297:Male; D017628:Microglia / Q000000981:diagnostic imaging* / Q000378:metabolism*; D008875:Middle Aged; D009422:Nervous System Diseases / Q000000981:diagnostic imaging* / Q000378:metabolism*; D010647:Phenyl Ethers / Q000493:pharmacokinetics*; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics*
chemical_list: D000081:Acetamides; C118942:DAA 1106; D007546:Isoquinolines; D010647:Phenyl Ethers; D019275:Radiopharmaceuticals; C037850:PK 11195
references.citation: Lancet. 1992 Apr 25;339(8800):1054-5
references.pmid: 1349076
references.citation: Neurobiol Dis. 2008 Feb;29(2):232-41
references.pmid: 17920902
references.citation: Exp Neurol. 2000 Jan;161(1):102-14
references.pmid: 10683277
references.citation: J Neurochem. 2000 Apr;74(4):1694-704
references.pmid: 10737628
references.citation: Neuroreport. 2000 Sep 11;11(13):2957-60
references.pmid: 11006973
references.citation: Brain. 2000 Nov;123 ( Pt 11):2321-37
references.pmid: 11050032
references.citation: Neurology. 2000 Oct 10;55(7):1052-4
references.pmid: 11061271
references.citation: Lancet. 2001 Aug 11;358(9280):461-7
references.pmid: 11513911
references.citation: Brain. 2001 Oct;124(Pt 10):2014-27
references.pmid: 11571219
references.citation: Glia. 2002 Nov;40(2):206-17
references.pmid: 12379908
references.citation: Eur J Neurol. 2003 May;10(3):257-64
references.pmid: 12752399
references.citation: J Clin Invest. 2004 Apr;113(7):981-9
references.pmid: 15057304
references.citation: Neurobiol Dis. 2004 Apr;15(3):601-9
references.pmid: 15056468
references.citation: Brain. 2004 Jun;127(Pt 6):1379-92
references.pmid: 15069023
references.citation: Mov Disord. 2004 Oct;19(10):1221-6
references.pmid: 15390000
references.citation: J Cereb Blood Flow Metab. 1991 Mar;11(2):314-22
references.pmid: 1997503
references.citation: Eur J Pharmacol. 1991 Aug 6;200(2-3):347-51
references.pmid: 1782994
references.citation: Neurosci Lett. 1994 Aug 15;177(1-2):35-8
references.pmid: 7824177
references.citation: J Neurosci. 1995 Jul;15(7 Pt 2):5263-74
references.pmid: 7623150
references.citation: J Nucl Med. 1995 Dec;36(12):2207-10
references.pmid: 8523106
references.citation: J Neurocytol. 1997 Feb;26(2):77-82
references.pmid: 9181482
references.citation: J Neurosci Res. 1997 Oct 15;50(2):345-53
references.pmid: 9373043
references.citation: Eur J Pharmacol. 1997 Dec 4;340(1):89-99
references.pmid: 9527511
references.citation: Neuroscience. 1998 Feb;82(3):805-17
references.pmid: 9483537
references.citation: Eur J Pharmacol. 1999 Apr 29;371(2-3):197-204
references.pmid: 10357257
references.citation: Neurosci Lett. 1999 Aug 13;271(1):5-8
references.pmid: 10471200
references.citation: Ann Neurol. 2004 Dec;56(6):894-7
references.pmid: 15562429
references.citation: Neuroimage. 2005 Jan 15;24(2):591-5
references.pmid: 15627603
references.citation: Ann Neurol. 2005 Feb;57(2):168-75
references.pmid: 15668962
references.citation: Mult Scler. 2005 Apr;11(2):127-34
references.pmid: 15794383
references.citation: J Neurovirol. 2005 Aug;11(4):346-55
references.pmid: 16162478
references.citation: Neurobiol Dis. 2005 Nov;20(2):550-61
references.pmid: 15916899
references.citation: Neurobiol Dis. 2006 Feb;21(2):404-12
references.pmid: 16182554
references.citation: Gut. 2006 Apr;55(4):547-53
references.pmid: 16210399
references.citation: J Neuropathol Exp Neurol. 2006 Mar;65(3):199-203
references.pmid: 16651881
references.citation: Neurology. 2006 Jun 13;66(11):1638-43
references.pmid: 16769933
references.citation: Stroke. 2006 Jul;37(7):1749-53
references.pmid: 16763188
references.citation: Eur J Neurosci. 2006 Aug;24(4):991-1000
references.pmid: 16930426
references.citation: J Neurovirol. 2006 Aug;12(4):262-71
references.pmid: 16966217
references.citation: Nat Rev Neurosci. 2007 Jan;8(1):57-69
references.pmid: 17180163
references.citation: Prog Neurobiol. 2006 Dec;80(6):308-22
references.pmid: 17156911
references.citation: Brain. 2007 Jul;130(Pt 7):1759-66
references.pmid: 17400599
references.citation: Neurology. 1999 Dec 10;53(9):2199-203
references.pmid: 10599809